Mona M Sabra

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. pmc Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases
    M M Sabra
    Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell College of Medicine, New York, New York 10065, USA
    J Clin Endocrinol Metab 98:E829-36. 2013
  2. doi request reprint Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans
    Mona M Sabra
    Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    Thyroid 22:877-83. 2012
  3. doi request reprint Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: a practical approach to clinical decision making
    R Michael Tuttle
    Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Oral Oncol 49:676-83. 2013
  4. doi request reprint Recombinant human thyroid-stimulating hormone to stimulate 131-I uptake for remnant ablation and adjuvant therapy
    Mona M Sabra
    Endocrinology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Endocr Pract 19:149-56. 2013
  5. pmc RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system
    Rebecca Zeuren
    Department of Endocrinology Service, Memorial Sloan Kettering Cancer Center, New York, New York
    Laryngoscope 125:2417-24. 2015
  6. doi request reprint Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases
    Mona M Sabra
    1 Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell College of Medicine, New York, New York
    Thyroid 24:1088-95. 2014
  7. pmc Modeled nitrate levels in well water supplies and prevalence of abnormal thyroid conditions among the Old Order Amish in Pennsylvania
    Briseis Aschebrook-Kilfoy
    Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD, USA
    Environ Health 11:6. 2012
  8. doi request reprint Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer
    Mona M Sabra
    1 Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell College of Medicine, New York, New York
    Thyroid 26:518-24. 2016
  9. pmc Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006
    Briseis Aschebrook-Kilfoy
    Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, MD, USA
    Thyroid 21:125-34. 2011

Detail Information

Publications9

  1. pmc Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases
    M M Sabra
    Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell College of Medicine, New York, New York 10065, USA
    J Clin Endocrinol Metab 98:E829-36. 2013
    ..In addition, we aimed to correlate clinical outcomes of RAI therapy with clinicopathological factors and tumor mutational status...
  2. doi request reprint Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans
    Mona M Sabra
    Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    Thyroid 22:877-83. 2012
    ....
  3. doi request reprint Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: a practical approach to clinical decision making
    R Michael Tuttle
    Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Oral Oncol 49:676-83. 2013
    ..Current thyroid cancer management guidelines call for a far more risk adapted approach to the selection of patients for post-operative RAI treatment...
  4. doi request reprint Recombinant human thyroid-stimulating hormone to stimulate 131-I uptake for remnant ablation and adjuvant therapy
    Mona M Sabra
    Endocrinology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Endocr Pract 19:149-56. 2013
    ..To review the current literature with regard to the use of recombinant human thyroid stimulating hormone (rhTSH) as an adjunct to radioactive iodine (RAI) remnant ablation and adjuvant therapy...
  5. pmc RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system
    Rebecca Zeuren
    Department of Endocrinology Service, Memorial Sloan Kettering Cancer Center, New York, New York
    Laryngoscope 125:2417-24. 2015
    ....
  6. doi request reprint Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases
    Mona M Sabra
    1 Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell College of Medicine, New York, New York
    Thyroid 24:1088-95. 2014
    ....
  7. pmc Modeled nitrate levels in well water supplies and prevalence of abnormal thyroid conditions among the Old Order Amish in Pennsylvania
    Briseis Aschebrook-Kilfoy
    Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD, USA
    Environ Health 11:6. 2012
    ..Nitrate intake from drinking water and dietary sources can interfere with the uptake of iodide by the thyroid, thus potentially impacting thyroid function...
  8. doi request reprint Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer
    Mona M Sabra
    1 Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell College of Medicine, New York, New York
    Thyroid 26:518-24. 2016
    ..This will help in defining the optimal time to start these therapies and better define their impact on structural disease progression...
  9. pmc Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006
    Briseis Aschebrook-Kilfoy
    Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, MD, USA
    Thyroid 21:125-34. 2011
    ..In this study, we assessed the incidence patterns by histologic type according to demographic and tumor characteristics to further our understanding of these cancers...